APHELION CAPITAL
Aphelion Capital is a venture capital firm focused on supporting the growth of innovative medical technology with an emphasis on fast to market, low capital intense products that reduce the cost of delivering quality healthcare. They leverage their considerable knowledge and deep networks to accelerate commercial success of a company. Their team has extensive experience investing in healthcare companies across both the private and public equity markets.
APHELION CAPITAL
Industry:
Health Care Health Diagnostics Home Health Care Medical Device Venture Capital
Founded:
2005-01-01
Status:
Active
Contact:
415-944-8123
Email Addresses:
[email protected]
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Euro Apple Mobile Web Clips Icon Content Delivery Network Wix Wix Media
Similar Organizations
BP Ventures
BP Ventures is a venture capital firm that identifies and invests in private and high-growth technology companies.
Group K Diagnostics
We put patient health 1st by revolutionizing rapid blood testing with a hand-held chemistry and ID analyzer for everyone, all in one.
InnaMed
Launching HomeLab, a gateway to personalized healthcare in the comfort and privacy of your home. Measure + Analyze + Enhance.
Instadiagnostics
Instadiagnostics Inc., is developing a rapid, quantitative, point-of-care (POC) diagnostic platform.
Quantitative Radiology Solutions
Quantitative Radiology Solutions offers advanced body-wide quantification of medical images.
Runway Healthcare
Runway Healthcare is a MedTech Accelerator investing in early-stage technologies that transform patients’ lives.
Stel Life
Stel Life simplifies health device connectivity for patients, care teams, and device companies.
TSVC
TSVC is a venture capital firm that focuses on seed-stage technology startups.
Vitara Biomedical
Vitara Biomedical develops a therapeutic platform to support premature infants.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-04-11 | Nectero Medical | Aphelion Capital investment in Series D - Nectero Medical | 96 M USD |
| 2024-04-04 | Biolinq | Aphelion Capital investment in Series D - Biolinq | 58 M USD |
| 2024-03-04 | Phagenesis | Aphelion Capital investment in Series D - Phagenesis | 42 M USD |
| 2022-07-08 | Moving Analytics | Aphelion Capital investment in Series A - Moving Analytics | 20 M USD |
| 2022-06-22 | Elucid | Aphelion Capital investment in Series B - Elucid | 27 M USD |
| 2021-11-02 | Biolinq | Aphelion Capital investment in Series B - Biolinq | 100 M USD |
| 2021-04-19 | Moving Analytics | Aphelion Capital investment in Seed Round - Moving Analytics | 6 M USD |
| 2021-04-09 | ExplORer Surgical | Aphelion Capital investment in Venture Round - ExplORer Surgical | 2.5 M USD |
| 2021-01-21 | MIVI Neuroscience | Aphelion Capital investment in Series B - MIVI Neuroscience | 35 M USD |
| 2021-01-14 | Koya Medical | Aphelion Capital investment in Series A - Koya Medical | 11 M USD |
More informations about "Aphelion Capital"
Aphelion Capital - Crunchbase Investor Profile
Aphelion Capital is a venture capital firm focused on supporting the growth of innovative medical technology with an emphasis on fast to market, low capital intense products that reduce the cost of delivering quality healthcare. They …See details»
Cardeation | Aphelion
Aphelion Capital has partnered with the American Heart Association, UPMC Enterprises, and Philips to form Cardeation Capital. ... The Dallas-based association is the nation’s oldest and largest voluntary organization dedicated …See details»
Aphelion Capital - Investments, Portfolio & Company Exits
Aphelion Capital 's most notable exits include Phagenesis, Bardy Diagnostics, and ExplORer Surgical. Which industries has this organization had the most exits in? Show . Phagenesis …See details»
Aphelion Capital – Jacobs Capital Group
Aphelion Capital invests in medical technology companies across all stages and therapeutic areas, but strongly prefers investments in companies with low capital requirements and short …See details»
Aphelion Capital investment portfolio - PitchBook
Aphelion Capital's latest investment was on 04-Sep-2024 in Venova Medical, a company within the Therapeutic Devices industry. Data Transparency. Meet our data hygiene team. Discover …See details»
Investment Strategy - Aphelion
Not all capital is created equal. At Aphelion, we work to provide meaningful support to our portfolio companies through our extensive network and active strategic limited partners. We work to …See details»
Edge Total Intelligence inc. Announcement - edgeTI
December 24, 2021 – Vancouver, British Columbia – Edge Total Intelligence Inc. (formerly Aphelion Capital Corp. (“Aphelion”)) (the “Company”) is pleased to announce: (i) the closing of its previously announced brokered private …See details»
Aphelion Capital - Funding, Financials, Valuation & Investors
Aphelion Capital . Connect to CRM . Save . Summary. Financials. Investments. People. Technology. Signals & News. Similar Companies. Highlights. Funds 5. Funding. Aphelion …See details»
Aphelion Capital - Zefyron Investor
Aphelion Capital is a venture capital firm focused on supporting the growth of innovative medical technology with an emphasis on fast to market, low capital int.See details»
New $30 Million Venture Capital Fund to Spur Innovation in Heart ...
May 30, 2018 Managed by Aphelion Capital, each of the three organizations has committed $10 million to the fund to bring products and solutions to market that address critical areas of …See details»
Cardeation Capital expands health care innovation in heart disease …
Jul 27, 2022 The American Heart Association, Phillips, Research Corporation Technologies, Inc. (RCT) and Aphelion Capital are collaborating to fund pioneering health care products and …See details»
Aphelion Capital - Private Equity List
Aphelion Capital is a venture capital firm focused on supporting the growth of innovative medical technology with an emphasis on fast to market, low capital intense products that reduce the …See details»
Ned Scheetz, Founder & Managing Partner, Aphelion Capital
Feb 3, 2016 Ned Scheetz is the General Partner and founder of Aphelion Capital. For over two decades, Mr. Scheetz has been an investor in numerous public and private healthcare …See details»
Ned Scheetz - Founder & Managing Partner @ Aphelion Capital ...
Mr. Scheetz founded Aphelion Capital, LLC in 2005. Prior to forming Aphelion, Mr. Scheetz was a partner and managing director with Piper Jaffray Ventures (PJV) for nearly eight years, …See details»
Cardeation Capital expands health care innova | EurekAlert!
Jul 27, 2022 Ned Scheetz, founder and managing partner of Aphelion Capital, said his organization is committed to investing in low capital-intensive entrepreneurial opportunities …See details»
Aphelion Capital Fund Manager Profile - Preqin
Founded in 2006, Aphelion Capital is a California-based venture capital firm that focuses on supporting the growth of innovative medical technology companies. The firm invests in seed to …See details»
Aphelion Capital firms up QT with Edge - stockwatch.com
Mar 16, 2021 Aphelion Capital Corp: Symbol: APHE: Shares Issued: 4,002,000: Recent Sedar Documents. View Original Document. Aphelion Capital firms up QT with Edge. 2021-03-16 …See details»
Paris dreams of becoming the capital of positive AI with the ...
1 day ago France will host 100 heads of state and some 600 business and NGO leaders from the USA and Europe, as well as China and Africa.See details»
Ned Scheetz | Mysite
Ned founded Aphelion Capital®, LLC in 2005 and has over 20 years of healthcare investing experience. Prior to forming Aphelion, Ned was a partner and managing director with Piper …See details»
Aphelion Capital - Contacts, Employees, Board Members
Aphelion Capital has 4 current employee profiles, including Founder & Managing Partner Ned Scheetz. Contacts. Edit Contacts Section. Job Department. Protected Content. Principal. Non …See details»